Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Myeloproliferative disorders (excl leukaemias)
ADR ID BADD_A02932
ADR Hierarchy
01      Blood and lymphatic system disorders
01.13      Haematopoietic neoplasms (excl leukaemias and lymphomas)
01.13.03      Myeloproliferative disorders (excl leukaemias)
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.21      Haematopoietic neoplasms (excl leukaemias and lymphomas)
16.21.03      Myeloproliferative disorders (excl leukaemias)
Description Not Available
MedDRA Code 10028578
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01567Nilotinib0.000392%
BADD_D01613Omega-3-fatty acids--
BADD_D01834Prednisone0.000018%
BADD_D01835Pregabalin0.000078%
BADD_D01847Procarbazine hydrochloride--
BADD_D01952Ritonavir--
BADD_D01954Rivaroxaban0.000158%
BADD_D01978Ruxolitinib0.008467%
BADD_D02007Semaxanib--
BADD_D02031Sitaxentan--
BADD_D02105Tacrolimus0.000743%
BADD_D02192Thalidomide0.001784%
BADD_D02331Valsartan0.000053%
BADD_D02346Venlafaxine--
BADD_D02365Vismodegib0.000112%
BADD_D02464Fingolimod0.000241%
BADD_D02554Fedratinib0.000492%
The 2th Page    First    Pre   2    Total 2 Pages